Erratum to ''An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA ( R)) in adults: safety, tolerability, and immunogenicity'' - [Vaccine 19 (2001) 3968-3971]

By Linglof T.   Hattum J.v.   Kaplan K.M.   Corrigan J.   Duval I.   Jensen E.   Kuter B.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 281-281

Elsevier

Access to resources Recommend Favorite

A randomized study of a flexible booster dosing regimen of VAQTA(R) in adults: safety, tolerability, and immunogenicity

By Hornick R.   Tucker R.   Kaplan K.M.   Eves K.A.   Banerjee D.   Jensen E.   Kuter B.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4727-4731

Elsevier

Access to resources Recommend Favorite

Comparison of immunogenicity of two hepatitis A vaccines - VAQTA(R) and HAVRIX(R) - in young adults

By Ashur Y.   Adler R.   Rowe M.   Shouval D.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2290-2296

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route

By Fisch A.   Cadilhac P.   Vidor E.   Prazuck T.   Dublanchet A.   Lafaix C.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1132-1136

Elsevier

Access to resources Recommend Favorite